Comprehensive Psychiatry
Volume 44, Issue 4 , Pages 293-302 , July 2003

Prevalence of human immunodeficiency virus, hepatitis b, and hepatitis c among homeless persons with co-occurring severe mental illness and substance use disorders

  • W.Dean Klinkenberg

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Dean Klinkenberg, Ph.D., Missouri Institute of Mental Health, 5400 Arsenal St, St Louis, MO 63139, USA
    • Missouri Institute of Mental Health, University of Missouri School of Medicine, St Louis, MO, USA
    • ,
  • Robert J Caslyn

      Affiliations

    • Gerontology Program, University of Missouri-St Louis, MO, USA
    • ,
  • Gary A Morse

      Affiliations

    • Community Alternatives, St Louis, MO, St Louis, MO, USA
    • ,
  • Robert D Yonker

      Affiliations

    • Department of Psychology, University of Missouri-St Louis, USA
    • ,
  • Suzanne McCudden

      Affiliations

    • Missouri Institute of Mental Health, University of Missouri School of Medicine, St Louis, MO, USA
    • ,
  • Fassil Ketema

      Affiliations

    • Department of Pathology, University of Maryland, Baltimore, MD, USA
    • ,
  • Niel T Constantine

      Affiliations

    • Department of Pathology, University of Maryland, Baltimore, MD, USA

References 

  1. Koranyi EK. Morbidity and rate of undiagnosed physical illness in a psychiatric clinic population. Arch Gen Psychiatry. 1979;36:414–419
  2. Maricle RA, Hoffman WF, Bloom JD, Faulkner FR, Keepers GA. The prevalence and significance of medical illness among chronically mentally ill outpatients. Community Ment Health J. 1987;23:81–90
  3. Segal SP, Kotler PL. A ten-year perspective of mortality risk among mentally ill patients in sheltered care. Hosp Community Psychiatry. 1991;42:708–713
  4. Koranyi EK. Fatalities in 2,070 psychiatric outpatients (preventive features). Arch Gen Psychiatry. 1977;34:1137–1142
  5. Segal SP, Vandervoort DJ, Liese LH. Residential status and physical health of a mentally ill population. Health Soc Work. 1993;18:208–214
  6. Tsuang MT, Woolson RI, Fleming J. Premature deaths in schizophrenia and affective disorders (an analysis of survival curves and variables affecting shortened survival). Arch Gen Psychiatry. 1980;37:979–983
  7. Tsasis P. Adherence assessment to highly active antiretroviral therapy. AIDS Patient Care STDS. 2001;15:109–115
  8. Ickovics JR, Meisler AW. Adherence in AIDS clinical trials (a framework for clinical research and clinical care). J Clin Epidemiol. 1997;50:385–391
  9. Centers for Disease Control and Prevention http://www.cdc.gov/ncidod/diseases/hepatitis/b/fact.htm, 2001.
  10. Centers for Disease Control and Prevention . Recommendations for the prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR19):1–39
  11. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91:42–46
  12. Diaz T, Des Jarlais DC, Vlahov D, Perlis TE, Edwards V, Friedman SR. Factors associated with prevalent hepatitis C (differences among young adult injection drug users in lower and upper Manhattan, New York City). Am J Public Health. 2001;91:23–30
  13. Carey MP, Weinhardt LS, Carey KB. Prevalence of infection with HIV among the seriously mentally ill (review of research and implications for practice). Prof Psychol Res Pract. 1995;26:262–268
  14. Cournos F. Epidemiology of HIV. In:  Cournos F,  Bakalar N editor. AIDS and People With Severe Mental Illness. New Haven, CT: Yale University Press; 1996;p. 3–14
  15. Grassi L. Risk of HIV infection in psychiatrically ill patients. AIDS Care. 1996;8:103–116
  16. Kalichman SC, Carey MP, Carey KB. Human immunodeficiency virus (HIV) risk among the seriously mentally ill. Clin Psychol Sci Pract. 1996;3:130–143
  17. Hatem DS, Hurowitz JC, Greene HL, Sullivan JL. Seroprevalence of human immunodeficiency virus in a state psychiatric institution. Arch Intern Med. 1990;150:2209
  18. Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, Butterfield MI. Prevalance of hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health. 2001;91:31–37
  19. Stewart DL, Zuckerman CJ, Ingle JM. HIV seroprevalence in a chronically mentally ill population. J Natl Med Assoc. 1994;86:519–523
  20. Ward BE, Myers MA, Rose M. HIV Prevalence in Patients at Delaware State Hospital. Dover, DE: Delaware Division of Public Health; 1994;
  21. McQuillan GM, Khare M, Karon JM, Schable CA, Vlahov D. Update on the seroepidemiology of human immunodeficiency virus in the United States household population (NHANES III, 1988-1994). J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:355–360
  22. Silberstein C, Galanter M, Marmor M, Kisshutz H, Krasinski K, Franco H. HIV-1 among inner city dually diagnosed inpatients. Am J Drug Alcohol Abuse. 1994;20:101–113
  23. Susser E, Valencia E, Conover S. Prevalence of HIV infection among psychiatric patients in a New York City men’s shelter. Am J Public Health. 1993;83:568–570
  24. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R, Non-patient Edition, (SCID-NP). Washington, DC: American Psychiatric Press; 1990;
  25. Chawarski MC, Pakes J, Schottenfeld RS. Assessment of HIV risk. J Addict Dis. 1998;17:49–59
  26. Drake RE, Osher FC, Wallach MA. Alcohol use and abuse in schizophrenia (a prospective community study). J Nerv Ment Dis. 1989;177:136–138
  27. Carey KB, Cocco KM, Simons JS. Concurrent validity of clinicians’ ratings of substance abuse among psychiatric outpatients. Psychiatr Serv. 1996;47:842–847
  28. Kelly JA, Murphy DA, Sikkema KJ, Somlai AM, Mulry G, Fernandex MI. Predictors of high and low levels of HIV risk behavior among adults with chronic mental illness. Psychiatr Serv. 1995;46:813–818
  29. Kalichman SC, Kelly JA, Johnson JR, Bulto M. Factors associated with risk for HIV infection among chronic mentally ill adults. Am J Psychiatry. 1994;151:221–227
  30. Felker B, Yazel JJ, Short D. Mortality and medical comorbidity among psychiatric patients (a review). Psychiatr Serv. 1996;47:1356–1363
  31. Golomb B, Pyne JM, Wright B, Jaworski B, Lohr JB, Bozzette SA. The role of psychiatrists in primary care of patients with severe mental illness. Psychiatr Serv. 2000;51:766–773
  32. Centers for Disease Control and Prevention . Notice to readers (FDA approval for a combined hepatitis A and B vaccine). MMWR Morb Mortal Wkly Rep. 2001;50:806–807
  33. Haley N, Roy E, Belanger L, Crago AL. A hepatitis B vaccination outreach project for street youth in Montreal. Can J Hum Sexuality. 1998;7:331–338
  34. Savage RB, Hussey MJ, Hurie MB. A successful approach to immunizing men who have sex with men against hepatitis B. Public Health Nurs. 2000;17:202–206
  35. Kalichman SC, Sikkema KJ, Kelly JA, Bulto M. Use of a brief behavioral skills intervention to prevent HIV infection among chronic mentally ill adults. Psychiatr Serv. 1995;46:275–280
  36. Kelly JA, McAuliffe TL, Sikkema KJ, Murphy DA, Somlai AM, Mulry G. Reduction in risk behavior among adults with severe mental illness who learned to advocate for HIV prevention. Psychiatr Serv. 1997;48:1283–1288
  37. Susser E, Valencia E, Berkman A, Sohler N, Conover S, Torres J. Human immunodeficiency virus sexual risk reduction in homeless men with mental illness. Arch Gen Psychiatry. 1998;55:266–272
  38. Drake RE, Bartels SJ, Teague GB, Noordsy DL, Clark RE. Treatment of substance abuse in severely mentally ill patients. J Nerv Ment Dis. 1993;181:606–611
  39. Miller WR, Rollnick S. Motivational Interviewing. New York, NY: Guilford Press; 1991;
  40. Marlatt G. Harm Reduction (Pragmatic Strategies for Managing Risk Behaviors). New York, NY: Guilford Press; 1998;
  41. Missouri Department of Health . 2000 Epidemiological Profiles of HIV Disease and STDs in St. Louis HIV Region. Jefferson City, MO: Missouri Department of Health; 2001;
  42. Drake RE, Mueser KT. Psychosocial approaches to dual diagnosis. Schizophr Bull. 2000;26:105–118

☆ Supported by Grant No. R18 MH-51391 from the National Institute of Mental Health.

PII: S0010-440X(03)00094-4

doi: 10.1016/S0010-440X(03)00094-4

Comprehensive Psychiatry
Volume 44, Issue 4 , Pages 293-302 , July 2003

Article Tools